COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Preemptive Analgetic Potency of Low Dose S-Ketamine (Miniket)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01022840
Recruitment Status : Completed
First Posted : December 1, 2009
Last Update Posted : October 2, 2012
Information provided by (Responsible Party):
Andreas Sandner-Kiesling , MD, Medical University of Graz

Brief Summary:
The primary hypothesis is improved postoperative analgetic quality using S-Ketamine, particularly in patients suffering from chronic pain.

Condition or disease Intervention/treatment Phase
Pain Drug: S-Ketamine Other: Placebo Comparison Phase 3

Detailed Description:
The investigators are dealing mainly with the finding of the right dosage for the optimal safety and efficacy of S-Ketamine, but also discovering new possible areas of investigation (e.g. anti-depressive effect, anti-neuropathic effect).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Opioid Sparing Effect of Minimal Dose S-Ketamine Applied as a Coanalgesic During the Perioperative Period - An Active Placebo-Controlled, Double Blinded, Randomized Clinical Trial (МiniKet)
Study Start Date : February 2009
Actual Primary Completion Date : March 2012
Actual Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

Drug Information available for: Ketamine

Arm Intervention/treatment
Placebo Comparator: Placebo
Placebo as saline solution
Other: Placebo Comparison
saline control
Other Name: Placebo

Experimental: Low dose
Drug: S-Ketamine
Other Name: Ketanest

Active Comparator: High dose Drug: S-Ketamine
Other Name: Ketanest

Primary Outcome Measures :
  1. postoperative opioid consumption [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Scheduled for major abdominal surgery
  • Suitable for PCA
  • Cardio-vascular stable
  • Age: 18+
  • Between 50-120kg BW
  • ASA 1-3
  • Good Compliance for pain monitoring

Exclusion Criteria:

  • Allergy to S-Ketamine
  • Severe liver or kidney dysfunction
  • Severe coronary disease
  • Pregnancy
  • Present or past psychotic disorders
  • Addiction to alcohol or opioids
  • Poor compliance

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01022840

Layout table for location information
Medical University Graz
Graz, Styria, Austria, 8045
Medical University of Graz
Graz, Styria, Austria, 8045
Medical University of Graz
Graz, Austria, 8036
Sponsors and Collaborators
Medical University of Graz
Layout table for investigator information
Principal Investigator: Mischa Wejbora, MD Med. U Graz

Layout table for additonal information
Responsible Party: Andreas Sandner-Kiesling , MD, Univ. Prof. Dr., Medical University of Graz Identifier: NCT01022840    
Other Study ID Numbers: 180808
First Posted: December 1, 2009    Key Record Dates
Last Update Posted: October 2, 2012
Last Verified: October 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Central Nervous System Depressants
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Antidepressive Agents
Psychotropic Drugs